Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2014; 20(14): 3950-3959
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.3950
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.3950
Cancer | Cases | No. of cancers with mutation | No. of mutations | D-loop | rRNA | tRNA | mRNA | Ref. |
Adult leukemia | 24 | 9 (37.5) | 9 | 2 (22.2) | 1 (11.1) | 0 | 6 (66.7) | [16] |
Bladder cancer | 14 | 9 (64.3) | 20 | 6 (30.0) | 3 (15.0) | 0 | 11 (55.0) | [17] |
Breast cancer | 18 | 11 (61.1) | 12 | 7 (58.3) | 0 | 0 | 5 (41.7) | [18] |
19 | 14 (73.7) | 27 | 22 (81.5) | 1 (3.7) | 0 | 4 (14.8) | [19] | |
15 | 14 (93.3) | 45 | 17 (37.8) | 3 (6.7) | 2 (4.4) | 23 (51.1) | [20] | |
58 | 27 (46.6) | 40 | 21 (52.5) | 2 (5.0) | 2 (5.0) | 15 (37.5) | [21] | |
Esophageal cancer | 20 | 11 (55.0) | 14 | 9 (64.3) | 1 (7.1) | 0 | 4 (28.6) | [22] |
Follicular thyroid cancer | 3 | 3 (100.0) | 4 | 2 (50.0) | 2 (50.0) | 0 | 0 | [23] |
Gastric cancer | 31 | 20 (64.5) | 26 | 18 (69.2) | 0 | 1 (3.8) | 7 (26.9) | [15] |
Head-and-neck cancer | 13 | 6 (46.2) | 9 | 6 (66.7) | 1 (11.1) | 0 | 2 (22.2) | [17] |
Hepatocellular cancer | 10 | 5 (50.0) | 24 | 23 (95.8) | 0 | 0 | 1 (4.2) | [24] |
44 | 23 (52.3) | 34 | 21 (61.8) | 1 (2.9) | 2 (5.9) | 10 (29.4) | [25] | |
Lung cancer | 14 | 6 (47.1) | 10 | 7 (70.0) | 1 (10.0) | 2 (20.0) | 0 | [17] |
55 | 33 (60.0) | 56 | 18 (32.1) | 1 (1.8) | 3 (5.4) | 34 (60.7) | [26] | |
Medulloblastoma | 15 | 6 (40.0) | 18 | 11 (61.1) | 0 | 3 (16.7) | 4 (22.2) | [27] |
Oncocytic head-and-neck tumor | 25 | 16 (64.0) | 18 | 0 | 0 | 0 | 18 (100.0) | [28] |
Oncocytic pituitary adenoma | 25 | 18 (72.0) | 20 | 3 (15.0) | 0 | 2 (10.0) | 15 (75.0) | [28] |
Oncocytic thyroid tumor | 45 | 26 (57.8) | 30 | 0 | 0 | 0 | 30 (100.0) | [29] |
Oral cancer | 18 | 14 (77.8) | 26 | 20 (76.9) | 0 | 0 | 6 (23.1) | [30] |
300 | 240 (80.0) | 645 | 355 (55.0) | 36 (5.6) | 21 (3.3) | 233 (36.1) | [31] | |
Ovarian cancer | 10 | 6 (60.0) | 15 | 11 (73.3) | 3 (20.0) | 0 | 1 (6.7) | [32] |
Pancreatic cancer | 5 | 4 (80.0) | 4 | 0 | 1 (25.0) | 1 (25.0) | 2 (50.0) | [33] |
Papillary thyroid cancer | 7 | 3 (42.9) | 4 | 0 | 0 | 0 | 4 (100.0) | [23] |
Parathyroid adenoma | 30 | 15 (50.0) | 27 | 6 (22.2) | 1 (3.3) | 1 (3.3) | 19 (70.4) | [34] |
Renal cell cancer | 8 | 5 (62.5) | 6 | 1 (16.7) | 2 (33.3) | 0 | 3 (50.0) | [35] |
9 | 7 (77.8) | 9 | 4 (44.4) | 1 (11.1) | 1 (11.1) | 3 (33.3) | [36] | |
15 | 7 (46.7) | 14 | 4 (28.6) | 4 (28.6) | 1 (7.1) | 5 (35.7) | [37] | |
Renal oncocytomas | 9 | 9 (100.0) | 14 | 1 (7.1) | 0 | 0 | 13 (92.9) | [38] |
Total | 859 | 567 (66.0) | 1180 | 595 (50.5) | 65 (5.5) | 42 (3.6) | 478 (40.4) |
Cancer | Cases | No. of cancers with mutation (%) | No. of mutations | Transitions | Transversions | Mono-/di-nucleotide repeat instability | Others | Ref. |
Adult leukemia | 24 | 9 (37.5) | 9 | 9 (100.0) | 0 | 0 | 0 | [16] |
Bladder cancer | 14 | 9 (64.3) | 20 | 14 (70.0) | 3 (15.0) | 1 (5.0) | 2 (10.0) | [17] |
Breast cancer | 18 | 11 (61.1) | 12 | 6 (50.0) | 1 (8.3) | 5 (41.7) | 0 | [18] |
19 | 14 (73.7) | 27 | 22 (81.5) | 1 (3.7) | 4 (14.8) | 0 | [19] | |
15 | 14 (93.3) | 45 | 33 (73.3) | 7 (15.6) | 5 (11.1) | 0 | [20] | |
58 | 27 (46.6) | 40 | 20 (50.0) | 2 (5.0) | 17 (27.5) | 1 (2.5) | [21] | |
Esophageal cancer | 20 | 11 (55.0) | 14 | 3 (21.4) | 1 (7.1) | 9 (64.3) | 1 (7.1) | [22] |
Follicular thyroid cancer | 3 | 3 (100.0) | 4 | 3 (75.0) | 0 | 1 (25.0) | 0 | [23] |
Gastric cancer | 31 | 20 (64.5) | 26 | 12 (46.2) | 0 | 12 (46.2) | 2 (7.7) | [15] |
Head-and-neck cancer | 13 | 6 (46.2) | 9 | 7 (77.8) | 0 | 2 (22.2) | 0 | [17] |
Hepatocellular cancer | 10 | 5 (50.0) | 24 | 15 (62.5) | 0 | 9 (37.5) | 0 | [24] |
44 | 23 (52.3) | 34 | 19 (55.9) | 0 | 13 (38.2) | 2 (5.9) | [25] | |
Lung cancer | 14 | 6 (47.1) | 10 | 8 (80.0) | 1 (10.0) | 1 (10.0) | 0 | [17] |
55 | 33 (60.0) | 56 | 47 (83.9) | 1 (1.8) | 8 (14.3) | 0 | [26] | |
Medulloblastoma | 15 | 6 (40.0) | 18 | 13 (72.2) | 0 | 5 (27.8) | 0 | [27] |
Oncocytic head-and-neck tumor | 25 | 16 (64.0) | 18 | 13 (72.2) | 1 (5.6) | 1 (5.6) | 3 (16.7) | [28] |
Oncocytic pituitary adenoma | 25 | 18 (72.0) | 20 | 10 (50.0) | 0 | 9 (45.0) | 1 (5.0) | [28] |
Oncocytic thyroid tumor | 45 | 26 (57.8) | 30 | 22 (73.3) | 1 (3.3) | 5 (15.2) | 2 (6.7) | [29] |
Oral cancer | 18 | 14 (77.8) | 26 | 12 (46.2) | 4 (15.4) | 8 (30.8) | 2 (14.3) | [30] |
300 | 240 (80.0) | 645 | 356 (55.2) | 20 (3.1) | 237 (36.7) | 32 (5.0) | [31] | |
Ovarian cancer | 10 | 6 (60.0) | 15 | 10 (66.7) | 0 | 4 (26.7) | 1 (6.7) | [32] |
Pancreatic cancer | 5 | 4 (80.0) | 4 | 3 (75.0) | 1 (25.0) | 0 | 0 | [33] |
Papillary thyroid cancer | 7 | 3 (42.9) | 4 | 4 (100.0) | 0 | 0 | 0 | [23] |
Parathyroid adenoma | 30 | 15 (50.0) | 27 | 18 (66.7) | 1 (3.7) | 6 (22.2) | 2 (7.4) | [34] |
Renal cell cancer | 8 | 5 (62.5) | 6 | 2 (33.3) | 1 (16.7) | 1 (16.7) | 2 (33.3) | [35] |
9 | 7 (77.8) | 9 | 6 (66.7) | 0 | 3 (33.3) | 0 | [36] | |
15 | 7 (46.7) | 14 | 13 (92.9) | 1 (7.1) | 0 | 0 | [37] | |
Renal oncocytomas | 9 | 9 (100.0) | 14 | 7 (50.0) | 2 (14.3) | 4 (28.6) | 1 (7.1) | [38] |
Total | 859 | 567 (66.0) | 1180 | 707 (59.9) | 49 (4.2) | 370 (31.4) | 54 (4.6) |
- Citation: Lee HC, Huang KH, Yeh TS, Chi CW. Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression. World J Gastroenterol 2014; 20(14): 3950-3959
- URL: https://www.wjgnet.com/1007-9327/full/v20/i14/3950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i14.3950